share_log

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

简介-Cybin从Entheon Biomedical公司获得DMT临床研究
reuters ·  2022/06/07 21:05

June 7 (Reuters) - Cybin Inc CYBN.NLB :

路透6月7日电-Cybin Inc CYBN.NLB:

* CYBIN ACQUIRES DMT CLINICAL STUDY FROM ENTHEON BIOMEDICAL

*CyBIN从ENTHEON BioMedicine收购DMT临床研究

* CYBIN INC- PURCHASE PRICE OF ACQUISITION IS $1,000,000 (CAD)

*CyBIN Inc.-收购的购买价为1,000,000美元(加元)

Source text for Eikon: ID:nBw20D4Bma Further company coverage: CYBN.NLB

Eikon的源文本:ID:nBw20D4Bma进一步的公司报道:CYBN.NLB

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发